Abiraterone acetate 250mg Tablets_Birato 250_MSN_5970

Medicines Control Authority of Zimbabwe Follow

Medicines Control Authority of Zimbabwe @mcazofficial ·

8 Oct

As we celebrate Customer Service Week, now is a good time to familiarise yourself with the MCAZ Client Service Charter. Click the link below to read more about what customers can expect, including service standards: https://www.mcaz.co.zw/wp-content/uploads/2024/05/MCAZ-CSC-01-Rev-1_May-2024-Client-Service-Charter.pdf

Reply on Twitter 1843549639921832253 Retweet on Twitter 1843549639921832253 Like on Twitter 1843549639921832253 3 Twitter 1843549639921832253

Medicines Control Authority of Zimbabwe @mcazofficial ·

7 Oct

It’s Customer Service Week. We celebrate you, our valued customers and remain committed to providing the top-notch service that you always deserve #CustomerServiceWeek #AboveAndBeyond

Reply on Twitter 1843169888241885654 Retweet on Twitter 1843169888241885654 Like on Twitter 1843169888241885654 10 Twitter 1843169888241885654

UNICEF ZIMBABWE @unicefzimbabwe ·

3 Oct

Zimbabwe has achieved remarkable strides in immunization since 1982, and has one of the strongest immunization programmes in the Region. @MoHCCZim Minister Dr. Mombeshora speaks on the many vaccine interventions in 🇿🇼 over the years which have saved lives "My Health, My Right"

Reply on Twitter 1841806204017824238 Retweet on Twitter 1841806204017824238 7 Like on Twitter 1841806204017824238 19 Twitter 1841806204017824238

Medicines Control Authority of Zimbabwe @mcazofficial ·

2 Oct

1/ 📣INVITATION: The Authority invites Medicines and Medical products registration applicants and other relevant stakeholders to participate in a virtual meeting titled "Unpacking the New Medicines Registration Processes in Zimbabwe and Mapping Future Expectations"

Reply on Twitter 1841411036965953959 Retweet on Twitter 1841411036965953959 7 Like on Twitter 1841411036965953959 15 Twitter 1841411036965953959

Abiraterone acetate 250mg Tablets_Birato 250_MSN_5970

QUICK LINKS

FACEBOOK FEED

TWITTER FEED

CONTACT US